The content on this site is intended for healthcare professionals only
Dr Chai-Adisaksopha presents, at a press conference at ASH 2015, results from a study looking at switching patients to warfarin after 6-month completion of anticoagulant treatment for cancer-associated thrombosis.
Read the news story and watch the video interview for more information.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Best practice in HRRm testing in patients with metastatic prostate cancer
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
The current status of multiple myeloma diagnosis and treatment
